Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$104.47 - $116.17 $261,175 - $290,425
2,500 New
2,500 $269,000
Q1 2022

May 17, 2022

SELL
$108.42 - $129.58 $2.18 Million - $2.6 Million
-20,100 Reduced 21.73%
72,400 $9.27 Million
Q4 2021

Feb 15, 2022

BUY
$115.43 - $146.63 $3.87 Million - $4.91 Million
33,500 Added 56.78%
92,500 $11.8 Million
Q3 2021

Nov 16, 2021

BUY
$136.35 - $158.76 $3.74 Million - $4.35 Million
27,400 Added 86.71%
59,000 $8.64 Million
Q2 2021

Aug 16, 2021

SELL
$152.95 - $173.41 $18.6 Million - $21.1 Million
-121,600 Reduced 79.37%
31,600 $5.08 Million
Q1 2021

May 18, 2021

BUY
$148.16 - $159.71 $7.3 Million - $7.87 Million
49,300 Added 47.45%
153,200 $24.5 Million
Q4 2020

Feb 17, 2021

BUY
$128.25 - $151.41 $3.99 Million - $4.71 Million
31,100 Added 42.72%
103,900 $16 Million
Q3 2020

Nov 17, 2020

BUY
$113.59 - $141.68 $1.6 Million - $2 Million
14,100 Added 24.02%
72,800 $9.91 Million
Q2 2020

Aug 17, 2020

BUY
$87.02 - $133.4 $4.73 Million - $7.24 Million
54,300 Added 1234.09%
58,700 $7.01 Million
Q1 2020

May 15, 2020

SELL
$78.28 - $155.73 $31,312 - $62,291
-400 Reduced 8.33%
4,400 $445,000
Q4 2019

Feb 14, 2020

BUY
$127.4 - $146.83 $331,240 - $381,758
2,600 Added 118.18%
4,800 $718,000
Q3 2019

Nov 14, 2019

SELL
$113.33 - $138.46 $895,307 - $1.09 Million
-7,900 Reduced 78.22%
2,200 $302,000
Q2 2019

Aug 15, 2019

BUY
$108.87 - $125.09 $816,525 - $938,175
7,500 Added 288.46%
10,100 $1.19 Million
Q3 2018

Nov 14, 2018

SELL
$108.41 - $127.64 $292,707 - $344,628
-2,700 Reduced 50.94%
2,600 $342,000
Q4 2017

Feb 15, 2018

BUY
$105.55 - $120.83 $189,990 - $217,494
1,800 Added 51.43%
5,300 $640,000
Q3 2017

Nov 14, 2017

BUY
$106.92 - $117.79 $374,220 - $412,265
3,500
3,500 $410,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.6B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.